Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

01-12-2021 | Care | Research article

Risk of major bleeding by ethnicity and socioeconomic deprivation among 488,107 people in primary care: a cohort study

Authors: Wai Chung Tse, Corina Grey, Matire Harwood, Rod Jackson, Andrew Kerr, Suneela Mehta, Katrina Poppe, Romana Pylypchuk, Sue Wells, Vanessa Selak

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

Antithrombotic medications (antiplatelets and anticoagulants) reduce the risk of cardiovascular disease (CVD), but with the disadvantage of increasing bleeding risk. Ethnicity and socioeconomic deprivation are independent predictors of major bleeds among patients without CVD, but it is unclear whether they are also predictors of major bleeds among patients with CVD or atrial fibrillation (AF) after adjustment for clinical variables.

Methods

Prospective cohort study of 488,107 people in New Zealand Primary Care (including 64,420 Māori, the indigenous people of New Zealand) aged 30–79 years who had their CVD risk assessed between 2007 and 2016. Participants were divided into three mutually exclusive subgroups: (1) AF with or without CVD (n = 15,212), (2) CVD and no AF (n = 43,790), (3) no CVD or AF (n = 429,105). Adjusted hazards ratios (adjHRs) were estimated from Cox proportional hazards models predicting major bleeding risk for each of the three subgroups to determine whether ethnicity and socioeconomic deprivation are independent predictors of major bleeds in different cardiovascular risk groups.

Results

In all three subgroups (AF, CVD, no CVD/AF), Māori (adjHR 1.63 [1.39–1.91], 1.24 [1.09–1.42], 1.57 [95% CI 1.45–1.70], respectively), Pacific people (adjHR 1.90 [1.58–2.28], 1.30 [1.12–1.51], 1.62 [95% CI 1.49–1.75], respectively) and Chinese people (adjHR 1.53 [1.08–2.16], 1.15 [0.90–1.47], 1.13 [95% CI 1.01–1.26], respectively) were at increased risk of a major bleed compared to Europeans, although for Chinese people the effect did not reach statistical significance in the CVD subgroup. Compared to Europeans, Māori and Pacific peoples were generally at increased risk of all bleed types (gastrointestinal, intracranial and other bleeds). An increased risk of intracranial bleeds was observed among Chinese and Other Asian people and, in the CVD and no CVD/AF subgroups, among Indian people. Increasing socioeconomic deprivation was also associated with increased risk of a major bleed in all three subgroups (adjHR 1.07 [1.02–1.12], 1.07 [1.03–1.10], 1.10 [95% CI 1.08–1.12], respectively, for each increase in socioeconomic deprivation quintile).

Conclusion

Ethnicity and socioeconomic status should be considered in bleeding risk assessments to guide the use of antithrombotic medication for the management of AF and CVD.
Appendix
Available only for authorised users
Literature
2.
go back to reference Selak V, Jackson R, Poppe K, Wu B, Harwood M, Grey G, et al. Personalized prediction of cardiovascular benefits and bleeding harms from aspirin for primary prevention: a benefit–harm analysis. Ann Int Med. 2019;171:529–39.PubMedCrossRef Selak V, Jackson R, Poppe K, Wu B, Harwood M, Grey G, et al. Personalized prediction of cardiovascular benefits and bleeding harms from aspirin for primary prevention: a benefit–harm analysis. Ann Int Med. 2019;171:529–39.PubMedCrossRef
3.
go back to reference Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. J Am College Cardio. 2011;58:2432–46.CrossRef Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. J Am College Cardio. 2011;58:2432–46.CrossRef
4.
go back to reference January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JCJ, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circ. 2019;140:e125–51.CrossRef January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JCJ, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circ. 2019;140:e125–51.CrossRef
5.
go back to reference Wells S, Riddell T, Kerr A, Pylypchuk R, Chelimo C, Marshall R, et al. Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19). International Journal of Epidemiology. 2015;46(1):22. Wells S, Riddell T, Kerr A, Pylypchuk R, Chelimo C, Marshall R, et al. Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19). International Journal of Epidemiology. 2015;46(1):22.
6.
go back to reference Ministry of Health. Cardiovascular disease risk assessment: New Zealand Primary Care Handbook 2012. Updated 2013. Wellington: Ministry of Health; 2013. Ministry of Health. Cardiovascular disease risk assessment: New Zealand Primary Care Handbook 2012. Updated 2013. Wellington: Ministry of Health; 2013.
7.
go back to reference New Zealand Guidelines Group. Evidence-based best practice guideline. The assessment and management of cardiovascular risk. Wellington: New Zealand Guidelines Group; 2003. New Zealand Guidelines Group. Evidence-based best practice guideline. The assessment and management of cardiovascular risk. Wellington: New Zealand Guidelines Group; 2003.
8.
go back to reference Voss WB, Lee M, Devlin G, Kerr A, On behalf of the All New Zealand Acute Coronary Syndromes Quality Improvement (ANZACS-QI) investigators. Incidence and type of bleeding complications early and late after acute coronary syndrome admission in a New Zealand cohort (ANZACS-QI-7). NZMJ. 2016;129(1437):27–38. Voss WB, Lee M, Devlin G, Kerr A, On behalf of the All New Zealand Acute Coronary Syndromes Quality Improvement (ANZACS-QI) investigators. Incidence and type of bleeding complications early and late after acute coronary syndrome admission in a New Zealand cohort (ANZACS-QI-7). NZMJ. 2016;129(1437):27–38.
9.
go back to reference Hippisley-Cox J, Coupland D. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores. BMJ. 2014;349:g4606.PubMedPubMedCentralCrossRef Hippisley-Cox J, Coupland D. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores. BMJ. 2014;349:g4606.PubMedPubMedCentralCrossRef
10.
go back to reference Nishtala PS, Gnjidic D, Jamieson HA, Hanger HC, Kaluarachchi C, Hilmer SN. “Real-world” haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand. Int J Cardiol. 2016;203:716–52.CrossRef Nishtala PS, Gnjidic D, Jamieson HA, Hanger HC, Kaluarachchi C, Hilmer SN. “Real-world” haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand. Int J Cardiol. 2016;203:716–52.CrossRef
11.
go back to reference Rikala M, Kastarinen H, Tiittanen P, Huupponen R, Korhonen MJ. Natural history of bleeding and characteristics of early bleeders among warfarin initiators - a cohort study in Finland. Clin Epidemiol. 2016;8:23–35.PubMedPubMedCentral Rikala M, Kastarinen H, Tiittanen P, Huupponen R, Korhonen MJ. Natural history of bleeding and characteristics of early bleeders among warfarin initiators - a cohort study in Finland. Clin Epidemiol. 2016;8:23–35.PubMedPubMedCentral
12.
go back to reference Health Information Standards Organisation (HISO). HISO 10001:2017 Ethnicity Data Protocols. Wellington: Ministry of Health 2017. Health Information Standards Organisation (HISO). HISO 10001:2017 Ethnicity Data Protocols. Wellington: Ministry of Health 2017.
14.
go back to reference Salmond C, Crampton P, King P, Waldegrave C. NZiDep: a New Zealand index of socioeconomic deprivation for individuals. Soc Sci Med. 2005;62:1474–85.PubMedCrossRef Salmond C, Crampton P, King P, Waldegrave C. NZiDep: a New Zealand index of socioeconomic deprivation for individuals. Soc Sci Med. 2005;62:1474–85.PubMedCrossRef
15.
go back to reference Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef
16.
go back to reference Therneau T, Grambsch P, Fleming T. Martingale-based residuals for survival models. Biometrika. 1990;77:147–60.CrossRef Therneau T, Grambsch P, Fleming T. Martingale-based residuals for survival models. Biometrika. 1990;77:147–60.CrossRef
17.
go back to reference Selak V, Kerr A, Poppe K, Wu B, Harwood M, Grey C, et al. Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy. JAMA. 2018;319:2507–20.PubMedPubMedCentralCrossRef Selak V, Kerr A, Poppe K, Wu B, Harwood M, Grey C, et al. Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy. JAMA. 2018;319:2507–20.PubMedPubMedCentralCrossRef
18.
go back to reference Simpson BH, Reith D, Medlicott NJ, Smith A. Deprivation and inequalities lead to worse outcomes with dabigatran etexilate. J Prim Health Care. 2018;10:303–11.PubMedCrossRef Simpson BH, Reith D, Medlicott NJ, Smith A. Deprivation and inequalities lead to worse outcomes with dabigatran etexilate. J Prim Health Care. 2018;10:303–11.PubMedCrossRef
19.
go back to reference Irwin J, Ferguson R, Weilert F, Smith A. Incidence of upper gastrointestinal haemorrhage in Maori and New Zealand European ethnic groups, 2001–2010. Int Med J. 2014;44:755–841.CrossRef Irwin J, Ferguson R, Weilert F, Smith A. Incidence of upper gastrointestinal haemorrhage in Maori and New Zealand European ethnic groups, 2001–2010. Int Med J. 2014;44:755–841.CrossRef
20.
go back to reference Feigin V, Carter K, Hackett M, Barber PA, McNaughton H, Dyall L, et al. Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002–2003. Lancet Neurol. 2006;5:130–9.PubMedCrossRef Feigin V, Carter K, Hackett M, Barber PA, McNaughton H, Dyall L, et al. Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002–2003. Lancet Neurol. 2006;5:130–9.PubMedCrossRef
21.
go back to reference Crooks CJ, West J, Card TR. Upper gastrointestinal haemorrhage and deprivation: a nationwide cohort study of health inequality in hospital admissions. Gut. 2012;61:514–20.PubMedCrossRef Crooks CJ, West J, Card TR. Upper gastrointestinal haemorrhage and deprivation: a nationwide cohort study of health inequality in hospital admissions. Gut. 2012;61:514–20.PubMedCrossRef
22.
go back to reference Agyemang C, van Oeffelen AAM, Norredam M, Kappelle LJ, Klijn CJM, Bots ML, et al. Ethnic disparities in ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage incidence in The Netherlands. Stroke. 2014;45:3236–42.PubMedCrossRef Agyemang C, van Oeffelen AAM, Norredam M, Kappelle LJ, Klijn CJM, Bots ML, et al. Ethnic disparities in ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage incidence in The Netherlands. Stroke. 2014;45:3236–42.PubMedCrossRef
23.
go back to reference Labovitz DL, Halim AX, Brent B, Boden-Albala B, Hauser WA, Sacco RL. Subarachnoid hemorrhage incidence among whites, blacks and Caribbean Hispanics: the Northern Manhattan Study. Neuroepidemiology. 2006;26:147–50.PubMedCrossRef Labovitz DL, Halim AX, Brent B, Boden-Albala B, Hauser WA, Sacco RL. Subarachnoid hemorrhage incidence among whites, blacks and Caribbean Hispanics: the Northern Manhattan Study. Neuroepidemiology. 2006;26:147–50.PubMedCrossRef
24.
go back to reference Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35:426–31.PubMedCrossRef Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35:426–31.PubMedCrossRef
25.
go back to reference Broderick J, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992;12:733–6.CrossRef Broderick J, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992;12:733–6.CrossRef
26.
go back to reference Klatsky AL, Friedman GD, Sidney S, Kipp H, Kubo A, Armstrong MA. Risk of hemorrhagic stroke in Asian American ethnic groups. Neuroepidemiology. 2005;25:26–31.PubMedCrossRef Klatsky AL, Friedman GD, Sidney S, Kipp H, Kubo A, Armstrong MA. Risk of hemorrhagic stroke in Asian American ethnic groups. Neuroepidemiology. 2005;25:26–31.PubMedCrossRef
27.
go back to reference Bruno A, Carter S, Qualls C, Nolte KB. Incidence of spontaneous subarachnoid hemorrhage among Hispanics and non-Hispanic whites in New Mexico. Ethn Dis. 1997;7:27–33.PubMed Bruno A, Carter S, Qualls C, Nolte KB. Incidence of spontaneous subarachnoid hemorrhage among Hispanics and non-Hispanic whites in New Mexico. Ethn Dis. 1997;7:27–33.PubMed
28.
go back to reference Morgenstern LB, Smith MA, Lisabeth LD, Risser JMH, Uchino K, Garcia N, et al. Excess stroke in Mexican Americans compared with non-Hispanic whites. The Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol. 2004;160:376–83.PubMedCrossRef Morgenstern LB, Smith MA, Lisabeth LD, Risser JMH, Uchino K, Garcia N, et al. Excess stroke in Mexican Americans compared with non-Hispanic whites. The Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol. 2004;160:376–83.PubMedCrossRef
29.
go back to reference Eden SV, Meurer WJ, Sanchez BN, Lisabeth LD, Smith MA, Brown DL, et al. Gender and ethnic differences in subarachnoid hemorrhage. Neurology. 2008;71:731–5.PubMedPubMedCentralCrossRef Eden SV, Meurer WJ, Sanchez BN, Lisabeth LD, Smith MA, Brown DL, et al. Gender and ethnic differences in subarachnoid hemorrhage. Neurology. 2008;71:731–5.PubMedPubMedCentralCrossRef
30.
go back to reference Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community. The Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259–68.PubMedCrossRef Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community. The Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259–68.PubMedCrossRef
31.
go back to reference Nichols L, Stirling C, Otahal P, Stankovich J, Gall S. Socioeconomic disadvantage is associated with a higher incidence of aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2018;27:660–8.PubMedCrossRef Nichols L, Stirling C, Otahal P, Stankovich J, Gall S. Socioeconomic disadvantage is associated with a higher incidence of aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2018;27:660–8.PubMedCrossRef
32.
go back to reference Seo SR, Kim SY, Lee S-Y, Yoon T-H, Park H-G, Lee SE, et al. The incidence of stroke by socioeconomic status, age, sex, and stroke subtype: A nationwide study in Korea. J Prev Med Public Health. 2014;47:104–12.PubMedPubMedCentralCrossRef Seo SR, Kim SY, Lee S-Y, Yoon T-H, Park H-G, Lee SE, et al. The incidence of stroke by socioeconomic status, age, sex, and stroke subtype: A nationwide study in Korea. J Prev Med Public Health. 2014;47:104–12.PubMedPubMedCentralCrossRef
33.
go back to reference Jakovljevic D, Sivenius J, Sarti C, Torppa J, Mahonen M, Immonen-Raiha P, et al. Socioeconomic inequalities in the incidence, mortality and prognosis of subarachnoid hemorrhage: the FINMONICA Stroke Register. Cerebrovasc Dis. 2001;12:7–13.PubMedCrossRef Jakovljevic D, Sivenius J, Sarti C, Torppa J, Mahonen M, Immonen-Raiha P, et al. Socioeconomic inequalities in the incidence, mortality and prognosis of subarachnoid hemorrhage: the FINMONICA Stroke Register. Cerebrovasc Dis. 2001;12:7–13.PubMedCrossRef
34.
go back to reference Li C, Hedblad B, Rosvall M, Buchwald F, Khan FA, Engstrom G. Stroke incidence, recurrence, and case-fatality in relation to socioeconomic position. A population-based study of middle-aged Swedish men and women. Stroke. 2008;39:2191–6.PubMedCrossRef Li C, Hedblad B, Rosvall M, Buchwald F, Khan FA, Engstrom G. Stroke incidence, recurrence, and case-fatality in relation to socioeconomic position. A population-based study of middle-aged Swedish men and women. Stroke. 2008;39:2191–6.PubMedCrossRef
35.
go back to reference Lisabeth LD, Smith MA, Sanchez BN, Brown DL. Ethnic disparities in stroke and hypertension among women: the BASIC Project. Am J Hypertens. 2008;21:778–83.PubMedCrossRef Lisabeth LD, Smith MA, Sanchez BN, Brown DL. Ethnic disparities in stroke and hypertension among women: the BASIC Project. Am J Hypertens. 2008;21:778–83.PubMedCrossRef
36.
go back to reference Smeeton NC, Heuschmann PU, Rudd AG, McEvoy AW, Kitchen ND, Sarker SJ, et al. Incidence of hemorrhagic stroke in black Caribbean, black African, and white populations. The South London Stroke Register, 1995–2004. Stroke. 2007;38:3133–8.PubMedCrossRef Smeeton NC, Heuschmann PU, Rudd AG, McEvoy AW, Kitchen ND, Sarker SJ, et al. Incidence of hemorrhagic stroke in black Caribbean, black African, and white populations. The South London Stroke Register, 1995–2004. Stroke. 2007;38:3133–8.PubMedCrossRef
37.
go back to reference Flaherty ML, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36:934–7.PubMedCrossRef Flaherty ML, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36:934–7.PubMedCrossRef
38.
go back to reference Wolfe CDA, Rudd AG, Howard R, Coshall C, Stewart J, Lawrence E, et al. Incidence and case fatality rates of stroke subtypes in amultiethnic population: the South London Stroke Register. J Neurol Neurosurg Psychiatry. 2002;72:211–6.PubMedPubMedCentralCrossRef Wolfe CDA, Rudd AG, Howard R, Coshall C, Stewart J, Lawrence E, et al. Incidence and case fatality rates of stroke subtypes in amultiethnic population: the South London Stroke Register. J Neurol Neurosurg Psychiatry. 2002;72:211–6.PubMedPubMedCentralCrossRef
39.
go back to reference Howard VJ, Kleindorfer D, Judd S, McClure LA, Safford MM, Rhodes JD, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69:619–27.PubMedPubMedCentralCrossRef Howard VJ, Kleindorfer D, Judd S, McClure LA, Safford MM, Rhodes JD, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69:619–27.PubMedPubMedCentralCrossRef
40.
go back to reference Ahmed A, Armstrong M, Robertson I, Morris AJ, Blatchford O, Stanley AJ. Upper gastrointestinal bleeding in Scotland 2000–2010: Improved outcomes but a significant weekend effect. World J Gastroenterol. 2015;21:10890–7.PubMedPubMedCentralCrossRef Ahmed A, Armstrong M, Robertson I, Morris AJ, Blatchford O, Stanley AJ. Upper gastrointestinal bleeding in Scotland 2000–2010: Improved outcomes but a significant weekend effect. World J Gastroenterol. 2015;21:10890–7.PubMedPubMedCentralCrossRef
41.
go back to reference Cressman AM, Macdonald EM, Yao Z, Austin PC, Gomes T, Paterson JM, et al. Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: a population-based study. Am Heart J. 2015;170:133–40.PubMedCrossRef Cressman AM, Macdonald EM, Yao Z, Austin PC, Gomes T, Paterson JM, et al. Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: a population-based study. Am Heart J. 2015;170:133–40.PubMedCrossRef
42.
go back to reference Shen AYJ, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007;50:309–15.PubMedCrossRef Shen AYJ, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007;50:309–15.PubMedCrossRef
43.
go back to reference van Asch CJJ, Luitse MJA, Rinkel GJE, van der Tweel I, Algra A, Klijn CJM. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.PubMedCrossRef van Asch CJJ, Luitse MJA, Rinkel GJE, van der Tweel I, Algra A, Klijn CJM. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.PubMedCrossRef
44.
go back to reference Hippisley-Cox J, Coupland C. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores. BMJ. 2014;349:g4606.PubMedPubMedCentralCrossRef Hippisley-Cox J, Coupland C. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores. BMJ. 2014;349:g4606.PubMedPubMedCentralCrossRef
45.
go back to reference Harris R, Stanley J, Cormack DM. Racism and health in New Zealand: prevalence over time and associations between recent experience of racism and health and wellbeing measures using national survey data. PLoS ONE. 2018;13:e0196476.PubMedPubMedCentralCrossRef Harris R, Stanley J, Cormack DM. Racism and health in New Zealand: prevalence over time and associations between recent experience of racism and health and wellbeing measures using national survey data. PLoS ONE. 2018;13:e0196476.PubMedPubMedCentralCrossRef
46.
go back to reference Garcia JJL, Sharif MZ. Black lives matter: a commentary on racism and public health. Am J Public Health. 2015;105:e27–30.CrossRef Garcia JJL, Sharif MZ. Black lives matter: a commentary on racism and public health. Am J Public Health. 2015;105:e27–30.CrossRef
47.
go back to reference Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015;37:267–315.PubMedCrossRef Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015;37:267–315.PubMedCrossRef
48.
go back to reference Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139-228.PubMedCrossRef Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139-228.PubMedCrossRef
49.
go back to reference Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) bleeding score. Circ. 2009;119:1873–82.CrossRef Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) bleeding score. Circ. 2009;119:1873–82.CrossRef
50.
go back to reference Mehran R, Pocock S, Nikolsky E, Clayton T, Dangas G, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556–66.PubMedCrossRef Mehran R, Pocock S, Nikolsky E, Clayton T, Dangas G, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556–66.PubMedCrossRef
51.
go back to reference Moscucci M, Fox KAA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24:1815–23.PubMedCrossRef Moscucci M, Fox KAA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24:1815–23.PubMedCrossRef
52.
go back to reference Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillatio. Euro Heart Survey Chest. 2010;138:1093–100.PubMed Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillatio. Euro Heart Survey Chest. 2010;138:1093–100.PubMed
Metadata
Title
Risk of major bleeding by ethnicity and socioeconomic deprivation among 488,107 people in primary care: a cohort study
Authors
Wai Chung Tse
Corina Grey
Matire Harwood
Rod Jackson
Andrew Kerr
Suneela Mehta
Katrina Poppe
Romana Pylypchuk
Sue Wells
Vanessa Selak
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-01993-9

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue